You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Preleukemia

Showing 26 - 50 of 1,235
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Risk Myelodysplastic Syndrome Trial in Houston (Guadecitabine)

Active, not recruiting
  • High Risk Myelodysplastic Syndrome
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)

Recruiting
  • High Grade Myelodysplastic Syndromes
  • Aurora, Colorado
    Universtiy of Colorado Denver
Oct 19, 2021

MDS Trial (AG-946, Placebo)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
Aug 4, 2022

AML, MDS Trial in Tianjin (SHR-1702)

Active, not recruiting
  • AML
  • MDS
  • Tianjin, Tianjin, China
    Blood disease hospital of Chinese Academy of Medical Sciences
Mar 7, 2022

Acute Myeloid Leukemia and Myelodysplastic Syndrome Trial in Tianjin (QLF32101)

Not yet recruiting
  • Acute Myeloid Leukemia and Myelodysplastic Syndrome
  • Tianjin, Tianjin, China
    Institute of Hematology&Blood Diseases Hospital,Chinese Academy
Jan 27, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Boston (BXCL701)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 26, 2023

A Telehealth Advance Care Planning Intervention for Older Acute

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Telehealth
  • Rochester, New York
    University of Rochester
Jan 3, 2022

Leukemias, MDS Trial in Houston (sapacitabine)

Completed
  • Leukemias
  • Myelodysplastic Syndromes
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Dec 7, 2021

Acute Myeloid Leukemia, MDS Trial in Bronx (Venetoclax Oral Tablet, Daunorubicin, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Venetoclax Oral Tablet
  • +2 more
  • Bronx, New York
    Montefiore Einstein Cancer Center
Jul 14, 2022

MDS Trial in New Haven (CPX-351)

Withdrawn
  • MDS
  • New Haven, Connecticut
    Yale University; Smilow Cancer Center
Jan 6, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Sacramento (Lenalidomide)

Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Sacramento, California
    University of California Davis
Mar 8, 2022

MDS Trial in New York (selinexor (KPT-330))

Completed
Has Results
  • Myelodysplastic Syndromes
  • selinexor (KPT-330)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 11, 2022

Lower-risk Myelodysplastic Trial in Tokyo (ASTX727)

Active, not recruiting
  • Lower-risk Myelodysplastic
  • Tokyo, Japan
    NTT Medical Center Tokyo
Jan 14, 2022

Acute Myeloid Leukemia, MDS Trial in Rochester (Inpatient serious illness care program)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Inpatient serious illness care program
  • Rochester, New York
    University of Rochester
Jun 21, 2022

Analyze Occurrence of Transformation From Myelodysplastic

Completed
  • Myelodysplastic Syndromes
  • Leukemia, Myeloid, Acute
    • Kobe, Hyogo, Japan
      Shinko Hospital
    Jun 13, 2022

    Myelodysplastic Syndrome (MDS) Trial (FF-10501-01, Azacitidine)

    Withdrawn
    • Myelodysplastic Syndrome (MDS)
    • (no location specified)
    Jul 20, 2021

    MDS Trial in Dresden, Leipzig (Observational)

    Recruiting
    • Myelodysplastic Syndromes
    • Observational
    • Dresden, Germany
    • +1 more
    Aug 10, 2021

    MDS Trial in Innsbruck (Next Generation Sequencing, Tumorimmunological examinations - multiplex assays/quantitative polymerase

    Recruiting
    • Myelodysplastic Syndromes
    • Next Generation Sequencing
    • +5 more
    • Innsbruck, Tyrol, Austria
      Medical University of Innsbruck
    Apr 6, 2022

    MDS (MDS) Trial (Pevonedistat, Decitabine, Cedazuridine)

    Withdrawn
    • Myelodysplastic Syndromes (MDS)
    • (no location specified)
    Sep 23, 2021

    Leukemia Trial in Houston (Vosaroxin, Decitabine)

    Completed
    Has Results
    • Leukemia
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jan 13, 2022

    MDS, Thrombocytopenia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Thrombocytopenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 8, 2022

    Acute Myeloid Leukemia, MDS Trial in Rochester, Houston (CTX-712)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Rochester, Minnesota
    • +1 more
    Feb 15, 2023

    Myelodysplasia, Leukemia Trial in Providence (chemo)

    Terminated
    Has Results
    • Myelodysplasia
    • Leukemia
    • Providence, Rhode Island
      Lifespan Hospitals
    Jan 5, 2022

    MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • (no location specified)
    Nov 29, 2021

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)

    Active, not recruiting
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
    • Gemtuzumab Ozogamicin
    • Valhalla, New York
      New York Medical College
    Nov 11, 2021